The Botnar Institute of Immune Engineering (BIIE) is a newly founded research institute in Basel that serves as a hub for multidisciplinary science, uniting experts in immunology, bioengineering, computational biology, and AI. Our mission is to develop cutting-edge immune-based therapeutics and diagnostics by leveraging advanced computational tools.
Baxiva is a pre-seed biotechnology startup developing an advanced glycoconjugate vaccine targeting Extraintestinal pathogenic Escherichia coli (ExPEC), a leading cause of urinary tract infections and sepsis worldwide.
This position, based in Zurich, Switzerland, is a collaboration between the BIIE Molecular Mucosal Immunology group and Baxiva and offers the unique opportunity to work on cutting edge science with a focus on real-world clinical impact. If you are passionate about vaccinology and excited to collaborate in a diverse and dynamic environment, we encourage you to apply.
We are recruiting a Vaccine Immunologist to support development of a glycoconjugate vaccine targeting ExPEC. The Vaccine Immunologist will lead the generation and characterization of antigen-specific monoclonal antibodies for use as standards and controls and is expected to broadly support progress towards GLP compliant preclinical studies. This is a fixed appointment of 10 months with possibility to extend the engagement subject to progress and funding availability.
Your responsibilities will include:
The Molecular Mucosal Immunology group is dedicated to fostering creativity in science. As part of the team, you will receive hands on training in relevant methods and support for your professional and personal growth.
Essential:
Preferred: